Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Consolidated net profit of ₹104.44 crores for FY2026 with ₹10.17 crores standalone profit in Q4.
SEBI show cause notice regarding historical share transactions of subsidiary remains unresolved.
Company proposed amalgamation with Axis Max Life and fund raise up to ₹1,600 crores.